🕵️ Arcadia Biosciences, Inc. ($RKDA)
SEC insider & ownership activity, last 12 months · CIK 1469443 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Aug 31, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Steven Boyd | 10.0% | 13G | Aug 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Sep 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Sep 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 10, 2026 | filing ↗ |
| Delisting notice (3.01) | Aug 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 31, 2026 | filing ↗ |
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Delisting notice (3.01) | Aug 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 1, 2026 | filing ↗ |
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 (5.08) | Jul 1, 2026 | filing ↗ |
| Other events (8.01) | Jul 1, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 11, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Auditor change (4.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 4, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 9, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 9, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jan 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 9, 2026 | filing ↗ |
| Agreement terminated (1.02) | Dec 24, 2025 | filing ↗ |